| # | Drug | Count |
|---|---|---|
| 0 | DOXORUBICIN | 17 |
| 1 | IFOSFAMIDE | 14 |
| 2 | IFOSFAMIDE FOR INJECTION | 14 |
| 3 | PAZOPANIB HYDROCHLORIDE | 14 |
| 4 | CISPLATIN | 11 |
| 5 | METHOTREXATE SODIUM | 11 |
| 6 | BLEOMYCIN | 10 |
| 7 | BLEOMYCIN SULFATE | 10 |
| 8 | ETOPOSIDE | 9 |
| 9 | METHOTREXATE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LAROTRECTINIB | 1 | 0.0011 |
| 1 | SODIUM IODIDE I 123 | 1 | 0.0011 |
| 2 | SODIUM IODIDE I 131 | 1 | 0.0010 |
| 3 | BLEOMYCIN SULFATE | 10 | 0.0010 |
| 4 | IFOSFAMIDE FOR INJECTION | 14 | 0.0007 |
| 5 | PAZOPANIB HYDROCHLORIDE | 14 | 0.0005 |
| 6 | FILGRASTIM-SNDZ | 1 | 0.0003 |
| 7 | RIFAMPICIN | 2 | 0.0002 |
| 8 | RITUXIMAB-ABBS | 1 | 0.0002 |
| 9 | DOXORUBICIN | 17 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 9 | 0.0001 |
| 1 | Penem Antibacterial [EPC] | 3 | 0.0001 |
| 2 | Antisense Oligonucleotide [EPC] | 1 | 0.0001 |
| 3 | Alkylating Drug [EPC] | 15 | 0.0001 |
| 4 | Integrin Receptor Antagonist [EPC] | 5 | 0.0001 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 6 | Platinum-based Drug [EPC] | 11 | 0.0000 |
| 7 | Rifamycin Antibacterial [EPC] | 1 | 0.0000 |
| 8 | Microtubule Inhibitor [EPC] | 4 | 0.0000 |
| 9 | Interferon beta [EPC] | 4 | 0.0000 |